Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.

Wu Z, Zhou P, He N, Zhai S

Open source

DOI
10.3389/fcvm.2022.966331
Published
2022
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2022.966331,
  title = {Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.},
  author = {Wu Z and Zhou P and He N and Zhai S},
  year = {2022},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2022.966331},
  url = {https://doi.org/10.3389/fcvm.2022.966331}
}

RIS

TY  - JOUR
TI  - Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.
AU  - Wu Z
AU  - Zhou P
AU  - He N
AU  - Zhai S
PY  - 2022
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2022.966331
UR  - https://doi.org/10.3389/fcvm.2022.966331
ER  - 

APA

Z, W., P, Z., N, H., & S, Z. (2022). Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2022.966331

Source records